The DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
Chemistry, Design, and Structure−Activity Relationship of Cocaine Antagonists
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTChemistry, Design, and Structure−Activity Relationship of Cocaine AntagonistsSatendra SinghView Author Information Department of Medicinal Chemistry and Pharmaceutics, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73190 Cite this: Chem. Rev. 2000, 100, 3, 925–1024Publication Date (Web):February 23, 2000Publication History Received28 May 1999Published online23 February 2000Published inissue 1 March 2000https://doi.org/10.1021/cr9700538Copyright © 2000 American Chemical SocietyRIGHTS & PERMISSIONSArticle Views3926Altmetric-Citations232LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit Read OnlinePDF (6 MB) Get e-AlertsSUBJECTS:Anions,Organic compounds,Pharmaceuticals,Screening assays,Selectivity Get e-Alerts
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds
Miyaura, N., & Suzuki, A. (1995) · Chemical Reviews · doi:10.1021/cr00039a007 · Cited by 12,817
A neural substrate of prediction and reward
Schultz, W., Dayan, P., & Montague, P. R. (1997) · Science · doi:10.1126/science.275.5306.1593 · Cited by 9,388
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Optimization of parameters for semiempirical methods II. Applications
Stewart, J. J. P. (1989) · Journal of Computational Chemistry · doi:10.1002/jcc.540100209 · Cited by 3,748
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Cyanohydridoborate anion as a selective reducing agent
Borch, R. F., Bernstein, M. D., & Durst, H. D. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00741a013 · Cited by 1,851
N-methoxy-n-methylamides as effective acylating agents
Nahm, S., & Weinreb, S. M. (1981) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)91316-4 · Cited by 1,798
Lanthanides in organic chemistry. 1. Selective 1,2 reductions of conjugated ketones
Luche, J. L. (1978) · Journal of the American Chemical Society · doi:10.1021/ja00475a040 · Cited by 1,209
Activated Dimethyl Sulfoxide: Useful Reagents for Synthesis
Mancuso, A. J., & Swern, D. (1981) · Synthesis · doi:10.1055/s-1981-29377 · Cited by 1,160
Preparation and reactions of polyfunctional organozinc reagents in organic synthesis
Knochel, P., & Singer, R. D. (1993) · Chemical Reviews · doi:10.1021/cr00022a008 · Cited by 1,045
The dopamine hypothesis of the reinforcing properties of cocaine
Kuhar, M. J., Ritz, M. C., & Boja, J. W. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90141-g · Cited by 987
Gawin, F. H., & Ellinwood, E. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805053181806 · Cited by 965
The pharmacology of cocaine related to its abuse.
Johanson, C. E., & Fischman, M. W. (1989) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00022-5 · Cited by 686
Drug-activation of brain reward pathways
Wise, R. A. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00063-5 · Cited by 684
Selective Chemical Catalysis by an Antibody
Pollack, S. J., Jacobs, J. W., & Schultz, P. G. (1986) · Science · doi:10.1126/science.3787262 · Cited by 631
Mechanisms of Catalysis of Nucleophilic Reactions of Carboxylic Acid Derivatives.
Bender, M. L. (1960) · Chemical Reviews · doi:10.1021/cr60203a005 · Cited by 631
Tramontano, A., Janda, K. D., & Lerner, R. A. (1986) · Science · doi:10.1126/science.3787261 · Cited by 605
Molecular characterization of the dopamine transporter
Giros, B., & Caron, M. G. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90029-j · Cited by 562
Koe, B. K. (1976) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30726-3 · Cited by 499
Giros, B., el Mestikawy, S., Godinot, N., Zheng, K., Han, H., Yang-Feng, T., & Caron, M. G. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08925-4 · Cited by 477
Ritz, M. C., Cone, E. J., & Kuhar, M. J. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90132-b · Cited by 465
Kitayama, S., Shimada, S., Xu, H., Markham, L., Donovan, D. M., & Uhl, G. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7782 · Cited by 396
National Household Survey on Drug Abuse: Main Findings 1998
US Department of Health and Human Services; Substance Abuse and Mental Health Services Administration; Office of Applied Studies (2000) · PsycEXTRA Dataset · doi:10.1037/e442572005-001 · Cited by 395
Bergman, J., Madras, B. K., Johnson, S. E., & Spealman, R. D. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20689-9 · Cited by 394
Coyle, J. T., & Snyder, S. H. (1969) · Science · doi:10.1126/science.166.3907.899 · Cited by 348
Xu, M., Hu, X.-T., Cooper, D. C., Moratalla, R., Graybiel, A. M., White, F. J., & Tonegawa, S. (1994) · Cell · doi:10.1016/0092-8674(94)90026-4 · Cited by 331
The pharmacological effect of citalopram resides in the (S)-(+)-enantiomer
Hyttel, J., B�ges�, K. P., Perregaard, J., & S�nchez, C. (1992) · Journal of Neural Transmission · doi:10.1007/bf01244820 · Cited by 323
Chemical achievement and hope for the future.
Pauling, L. (1948) · PubMed · Cited by 323
Giros, B., Wang, Y. M., Suter, S., McLeskey, S. B., Pifl, C., & Caron, M. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33961-3 · Cited by 322
Palladium-catalyzed cross-coupling reaction of organoboron compounds with organic triflates
Ohe, T., Miyaura, N., & Suzuki, A. (1993) · The Journal of Organic Chemistry · doi:10.1021/jo00060a041 · Cited by 321
Reith, M. E. A., Meisler, B. E., Sershen, H., & Lajtha, A. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90148-6 · Cited by 289
[3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.
Javitch, J. A., Blaustein, R. O., & Snyder, S. H. (1984) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14974-2 · Cited by 280
Kennedy, L. T., & Hanbauer, I. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb13666.x · Cited by 255
Fluoxetine reduces intravenous cocaine self-administration in rats
Carroll, M. E., Lac, S. T., Asencio, M., & Kragh, R. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90232-7 · Cited by 254
Jeffcoat, A. R., Perez-Reyes, M., Hill, J. M., Sadler, B. M., & Cook, C. E. (1989) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08737-9 · Cited by 254
Antibody-Catalyzed Degradation of Cocaine
Landry, D. W., Zhao, K., Yang, G. X.-Q., Glickman, M., & Georgiadis, T. M. (1993) · Science · doi:10.1126/science.8456315 · Cited by 252
Cocaine receptors labeled by [3H]2 beta-carbomethoxy-3 beta-(4-fluorophenyl)tropane.
Madras, B. K., Spealman, R. D., Fahey, M. A., Neumeyer, J. L., Saha, J. K., & Milius, R. A. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09647-6 · Cited by 250
Carroll, F. I., Lewin, A. H., Boja, J. W., & Kuhar, M. J. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00084a001 · Cited by 250
Neumeyer, J. L., Wang, S., Milius, R. A., Baldwin, R. M., Zea-Ponce, Y., Hoffer, P. B., Sybirska, E., Al-Tikriti, M., & Charney, D. S. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00114a027 · Cited by 239
Buck, K. J., & Amara, S. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12584 · Cited by 236
Andersen, P. H. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb05752.x · Cited by 229
The Immunological Evolution of Catalysis
Patten, P. A., Gray, N. S., Yang, P. L., Marks, C. B., Wedemayer, G. J., Boniface, J. J., Stevens, R. C., & Schultz, P. G. (1996) · Science · doi:10.1126/science.271.5252.1086 · Cited by 227
Efficacy of a therapeutic cocaine vaccine in rodent models
Fox, B. S., Kantak, K. M., Edwards, M. A., Black, K. M., Bollinger, B. K., Botka, A. J., French, T. L., Thompson, T. L., Schad, V. C., Greenstein, J. L., et al. (1996) · Nature Medicine · doi:10.1038/nm1096-1129 · Cited by 220
Suppression of psychoactive effects of cocaine by active immunization
Carrera, M. R. A., Ashley, J. A., Parsons, L. H., Wirsching, P., Koob, G. F., & Janda, K. D. (1995) · Nature · doi:10.1038/378727a0 · Cited by 220
Clarke, R., Daum, S., Gambino, A., Aceto, M., Pearl, J., Levitt, M., Cuminskey, W., & Bogado, E. (1973) · Journal of Medicinal Chemistry · doi:10.1021/jm00269a600 · Cited by 217
Searle, M. S., Williams, D. H., & Gerhard, U. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00053a003 · Cited by 212
Cocaine binding at σ receptors
Sharkey, J., Glen, K. A., Wolfe, S., & Kuhar, M. J. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90058-1 · Cited by 206
Pharmacotherapies for Treatment of Cocaine Abuse: Preclinical Aspects
Carroll, F. I., Howell, L. L., & Kuhar, M. J. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9706729 · Cited by 203
Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters
Gatley, S. J., Pan, D., Chen, R., Chaturvedi, G., & Ding, Y.-S. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00052-5 · Cited by 203
Pharmacology of the enantiomers of threo-methylphenidate.
Patrick, K. S., Caldwell, R. W., Ferris, R. M., & Breese, G. R. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-5347(25)00340-4 · Cited by 196
CNS stimulants: two distinct mechanisms of action for amphetamine-like drugs
McMillen, B. A. (1983) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(83)90477-7 · Cited by 195
Walsh, S. L., & Cunningham, K. A. (1997) · Psychopharmacology · doi:10.1007/s002130050210 · Cited by 192
Carroll, F. I., Kotian, P., Dehghani, A., Gray, J. L., Kuzemko, M. A., Parham, K. A., Abraham, P., Lewin, A. H., Boja, J. W., & Kuhar, M. J. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00002a020 · Cited by 187
Appetite Suppressants: A Review
Silverstone, T. (1992) · Drugs · doi:10.2165/00003495-199243060-00003 · Cited by 183
Richardson, N. R., & Roberts, D. C. S. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90248-a · Cited by 181
Wong, D. F., Yung, B., Dannals, R. F., Shaya, E. K., Ravert, H. T., Chen, C. A., Chan, B., Folio, T., Scheffel, U., Ricaurte, G. A., et al. (1993) · Synapse · doi:10.1002/syn.890150205 · Cited by 174
Janowsky, A., Berger, P., Vocci, F., Labarca, R., Skolnick, P., & Paul, S. M. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb00649.x · Cited by 171
Release of dopamine via the human transporter.
Eshleman, A., Henningsen, R. A., Neve, K., & Janowsky, A. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09929-8 · Cited by 168
Neumeyer, J. L., Campbell, A., Wang, S., Gao, Y., Milius, R. A., Kula, N. S., Baldessarini, R. J., Zea-Ponce, Y., Baldwin, R. M., & Innis, R. B. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00037a004 · Cited by 164
Kinetics and Block of Dopamine Uptake in Synaptosomes from Rat Caudate Nucleus
Krueger, B. K. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08847.x · Cited by 155
Meegalla, S. K., Plöessl, K., Kung, M., Chumpradit, S., Stevenson, D. A., Kushner, S. A., McElgin, W., Mozley, P. D., & Kung, H. F. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960532j · Cited by 155
Schweri, M. M., Skolnick, P., Rafferty, M. F., Rice, K. C., Janowsky, A. J., & Paul, S. M. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb05524.x · Cited by 151
Spealman, R. D., Madras, B. K., & Bergman, J. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20686-3 · Cited by 150
Heidbreder, C. A., Goldberg, S. R., & Shippenberg, T. S. (1993) · Brain Research · doi:10.1016/0006-8993(93)90228-f · Cited by 146
Carroll, F. I., Gao, Y., Rahman, M. A., et al. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00113a008 · Cited by 146
Davies, H. M. L., Saikali, E., & Young, W. B. (1991) · The Journal of Organic Chemistry · doi:10.1021/jo00019a044 · Cited by 142
Meltzer, P. C., Liang, A. Y., Brownell, A., Elmaleh, D. R., & Madras, B. K. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00059a010 · Cited by 136
Binding characteristics of the dopamine uptake inhibitor [3H]nomifensine to striatal membranes
Dubocovich, M. L., & Zahniser, N. R. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90486-1 · Cited by 132
Emond, P., Garreau, L., Chalon, S., Boazi, M., Caillet, M., Bricard, J., FRANGIN, Y., Mauclaire, L., Besnard, J., & Guilloteau, D. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960795d · Cited by 132
GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine
Rothman, R. B., Mele, A., Reid, A. A., Akunne, H. C., Greig, N. H., Thurkauf, A., de Costa, B. R., Rice, K. C., & Pert, A. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90570-r · Cited by 127
Rothman, R. B. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90466-5 · Cited by 126
Withers, N. W., Pulvirenti, L., Koob, G. F., & Gillin, J. C. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199502000-00010 · Cited by 123
Volkow, N. D., Ding, Y., Fowler, J. S., & Wang, G. (1996) · Journal of Addictive Diseases · doi:10.1300/j069v15n04_04 · Cited by 121
Methylphenidate Treatment of Cocaine Abusers without Attention Deficit Disorder: A Negative Report
Gawin, F. H., Riordan, C. E., & Kleber, H. D. (1985) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952998509016861 · Cited by 120
[125I]RTI-55: a potent ligand for dopamine transporters
Boja, J. W., Patel, A. P., Carroll, F. I., Rahman, M. A., Abraham, P., Lewin, A. H., Kopajtic, T. A., & Kuhar, M. J. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90137-f · Cited by 120
Quantification of Steric Effects in Organometallic Chemistry
White, D., & Coville, N. J. (1994) · Advances in organometallic chemistry · doi:10.1016/s0065-3055(08)60390-1 · Cited by 120
Newman, A. H., Allen, A. C., Izenwasser, S., & Katz, J. L. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00041a002 · Cited by 119
Murray, J. S., Ranganathan, S., & Politzer, P. A. (1991) · The Journal of Organic Chemistry · doi:10.1021/jo00011a060 · Cited by 118
Porrino, L. J., Ritz, M. C., Goodman, N. L., Sharpe, L. G., Kuhar, M. J., & Goldberg, S. R. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90418-9 · Cited by 117
Wirsching, P., Ashley, J. A., Lo, C. L., et al. (1995) · Science · doi:10.1126/science.270.5243.1775 · Cited by 117
Dopamine receptor agonists, partial agonists and psychostimulant addiction
Pulvirenti, L., & Koob, G. F. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90158-9 · Cited by 114
Saturable (3H)cocaine binding in central nervous system of mouse
Reith, M. E. A., Sershen, H. W., & Lajtha, Á. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90029-6 · Cited by 108
Agoston, G. E., Wu, J. H., Izenwasser, S., George, C. F., Katz, J. L., Kline, R. H., & Newman, A. H. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970525a · Cited by 108
Antibody catalysis approaching the activity of enzymes
Tramontano, A., Ammann, A. A., & Lerner, R. A. (1988) · Journal of the American Chemical Society · doi:10.1021/ja00215a045 · Cited by 106
Gatley, S. J. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90665-r · Cited by 103
Deutsch, H. M., Shi, Q., Gruszecka‐Kowalik, E., & Schweri, M. M. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950697c · Cited by 103
Panizzon, L. (1944) · Helvetica Chimica Acta · doi:10.1002/hlca.194402701222 · Cited by 98
σ Receptor antagonists block the development of sensitization to cocaine
Ujike, H., Kuroda, S., & Otsuki, S. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00693-1 · Cited by 96
Ritz, M. C., & George, F. R. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10150-x · Cited by 96
Terry, P., Witkin, J. M., & Katz, J. L. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22507-1 · Cited by 95
2.beta.-Substituted analogs of cocaine. Synthesis and inhibition of binding to the cocaine receptor
Lewin, A. H., Gao, Y., Abraham, P., Boja, J. W., Kuhar, M. J., & Carroll, F. I. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00079a017 · Cited by 90
Meier, R., Groß, F., & Tripod, J. (1954) · Journal of Molecular Medicine · doi:10.1007/bf01466968 · Cited by 89
Neumeyer, J. L., Tamagnan, G. D., Wang, S., Gao, Y., Milius, R. A., Kula, N. S., & Baldessarini, R. J. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9505324 · Cited by 87
Goodman, M. M., Kung, M., Kabalka, G. W., Kung, H. F., & Switzer, R. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00036a020 · Cited by 86
Therapeutic Use of Butyrylcholinesterase for Cocaine Intoxication
Mattes, C. E., Lynch, T. J., Singh, A., Bradley, R. M., Kellaris, P. A., Brady, R. O., & Dretchen, K. L. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1997.8188 · Cited by 85
Davies, H. M. L., Saikali, E., Huby, N. J. S., Gilliatt, V. J., Matasi, J. J., Sexton, T., & Childers, S. R. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00035a005 · Cited by 82
Central and peripheral cocaine receptors.
Calligaro, D. O., & Eldefrawi, M. E. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39254-2 · Cited by 81
A portion of [3H]cocaine binding in brain is associated with serotonergic neurons.
Reith, M. E. A., Sershen, H. W., Allen, D. L., & Lajtha, Á. (1983) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14330-7 · Cited by 81
Mediation of the Discriminative Stimulus Properties of Cocaine by Mesocorticolimbic Dopamine Systems
Callahan, P. M., Garza, R. D. L., & Cunningham, K. A. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00434-0 · Cited by 80
Pharmacotherapy of cocaine abuse: Preclinical development
Witkin, J. M. (1994) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)90042-6 · Cited by 79
Glowa, J. R., Wojnicki, F. H. E., Matecka, D., Bacher, J. D., Mansbach, R. S., Balster, R. L., & Rice, K. C. (1995) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.3.3.219 · Cited by 78
Boja, J. W., Kuhar, M. J., Kopajtic, T. A., Yang, E., Abraham, P., Lewin, A. H., & Carroll, F. I. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00034a021 · Cited by 77
Reactivity-selectivity in the Swern oxidation of alcohols using dimethyl sulfoxide-oxalyl chloride
Marx, M., & Tidwell, T. T. (1984) · The Journal of Organic Chemistry · doi:10.1021/jo00179a009 · Cited by 76
Effects of cocaine alone and in combination with mazindol in human cocaine abusers.
Preston, K. L., Sullivan, J. T., Berger, P. A., & Bigelow, G. E. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39434-6 · Cited by 75
Rothman, R. B., Lewis, B., Dersch, C. M., Xu, H., Radesca, L. R., de Costa, B. R., Rice, K. C., Kilburn, R. B., Akunne, H. C., & Pert, A. (1993) · Synapse · doi:10.1002/syn.890140106 · Cited by 74
Bennett, B. A., Wichems, C. H., Hollingsworth, C. K., Davies, H. M. L., Thornley, C., Sexton, T., & Childers, S. R. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24543-8 · Cited by 74
Carroll, F. I., Abraham, P., Lewin, A. H., Parham, K., Boja, J. W., & Kuhar, M. J. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00091a019 · Cited by 73
Glowa, J. R., Fantegrossi, W. E., Lewis, D. B., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960551t · Cited by 73
Synthesis and pharmacology of hydroxylated metabolites of methyl phenidate
Patrick, K. S., Kilts, C. D., & Breese, G. R. (1981) · Journal of Medicinal Chemistry · doi:10.1021/jm00142a021 · Cited by 72
Matecka, D., Rothman, R. B., Radesca, L. A., de Costa, B. R., Dersch, C. M., Partilla, J. S., Pert, A., Glowa, J. R., Wojnicki, F. H. E., & Rice, K. C. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960305h · Cited by 72
Burke, T. R., Bajwa, B. S., Jacobson, A. E., Rice, K. C., Streaty, R. A., & Klee, W. A. (1984) · Journal of Medicinal Chemistry · doi:10.1021/jm00378a008 · Cited by 71
A potential vaccine for cocaine abuse prophylaxis
Bagasral, O., FORMAN, L. J., Howeedy, A. A., & Whittle, P. (1992) · Immunopharmacology · doi:10.1016/0162-3109(92)90023-6 · Cited by 69
Excitatory amino acids and the actions of cocaine
Karler, R., & Calder, L. D. (1992) · Brain Research · doi:10.1016/0006-8993(92)90329-8 · Cited by 69
DRUGS IN MANAGEMENT OF MINIMAL BRAIN DYSFUNCTION
Millichap, J. G. (1973) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1973.tb43189.x · Cited by 68
Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters.
Seibyl, J. P., Laruelle, M. A., van Dyck, C. H., Wallace, E. A., Baldwin, R. M., Zoghbi, S. S., Zea‐Ponce, Y., Neumeyer, J. L., Charney, D. S., Hoffer, P. B., et al. (1996) · PubMed · Cited by 66
N-Modified analogs of cocaine: synthesis and inhibition of binding to the cocaine receptor
Abraham, P., Pitner, J. B., Lewin, A. H., Boja, J. W., Kuhar, M. J., & Carroll, F. I. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00079a018 · Cited by 64
Ritz, M. C., & George, F. R. (1997) · Psychopharmacology · doi:10.1007/s002130050197 · Cited by 63
Interactions of cocaine and cocaine congeners with sodium channels
Matthews, J. C., & Collins, A. (1983) · Biochemical Pharmacology · doi:10.1016/0006-2952(83)90523-3 · Cited by 62
Tight binding dopamine reuptake inhibitors as cocaine antagonists
Rothman, R. B., Mele, A., Reid, A. A., Akunne, H. C., Greig, N. H., Thurkauf, A., Rice, K. C., & Pert, A. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81566-2 · Cited by 61
Janowsky, A. J., Schweri, M. M., Berger, P. A., et al. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90724-1 · Cited by 61
Søgaard, U., MICHALOW, J., BUTLER, B., Laursen, A. L., INGERSEN, S. H., Skrumsager, B. K., & Rafaelsen, O. J. (1990) · International Clinical Psychopharmacology · doi:10.1097/00004850-199010000-00001 · Cited by 61
Izenwasser, S., Terry, P., Heller, B., Witkin, J. M., & Katz, J. L. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90723-4 · Cited by 61
Jackson, A. G., Kenner, G. W., Moore, G. A., Ramage, R., & THORPE, W. D. (1976) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)92978-2 · Cited by 60
Rothman, R. B., Cadet, J. L., Akunne, H. C., Silverthorn, M. L., Baumann, M. H., Carroll, F. I., Rice, K. C., COSTA, B. R. D., Partilla, J. S., & Wang, J. B. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22365-5 · Cited by 60
Gatley, S. J., MacGregor, R. R., Fowler, J. S., Wolf, A. P., Dewey, S. L., & Schlyer, D. J. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb01933.x · Cited by 58
5-HT3 receptor antagonists block cocaine-induced locomotion via a PCPA-sensitive mechanism
Svingos, A. L., & HITZEMANN, R. J. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90420-k · Cited by 58
Kozikowski, A. P., Roberti, M., Li, X., Bergmann, J. S., Callahan, P. M., Cunningham, K. A., & Johnson, K. M. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00103a015 · Cited by 58
[3H]GBR 12935 binding in vivo in mouse brain: labelling of a piperazine acceptor site
Andersen, P. H., Jansen, J. A., & Nielsen, E. B. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90002-1 · Cited by 57
Probes for the cocaine receptor. Potentially irreversible ligands for the dopamine transporter
Carroll, F. I., Gao, Y., Abraham, P., Lewin, A. H., Lew, R., Patel, A. P., Boja, J. W., & Kuhar, M. J. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00088a017 · Cited by 56
Binding of bromine-substituted analogs of methylphenidate to monoamine transporters
Pan, D., Gatley, S. J., Dewey, S. L., Chen, R., Alexoff, D., Ding, Y., & Fowler, J. S. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)00460-9 · Cited by 56
Ho, G., Emerson, K. M., Mathre, D. J., Shuman, R. F., & Grabowski, E. J. J. (1995) · The Journal of Organic Chemistry · doi:10.1021/jo00116a057 · Cited by 55
Froimowitz, M., Patrick, K. S., & Cody, V. (1995) · Pharmaceutical Research · doi:10.1023/a:1016262815984 · Cited by 53
Johnson, K. M., Bergmann, J. S., & Kozikowski, A. P. (1992) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(92)90159-s · Cited by 53
Locomotor effects of cocaine, cocaine congeners, and local anesthetics in mice
Reith, M. E. A., Meisler, B. E., & Lajtha, A. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90078-4 · Cited by 53
Blough, B. E., Abraham, P., Lewin, A. H., Kuhar, M. J., Boja, J. W., & Carroll, F. I. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960409s · Cited by 52
Asymmetric Synthesis and Pharmacology of Methylphenidate and Its Para-Substituted Derivatives
Thai, D. L., Sapko, M. T., Reiter, C. T., Bierer, D. E., & Perel, J. M. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970620j · Cited by 52
Glutamate receptor antagonists block cocaine-induced convulsions and death
Rockhold, R. W., O'Den, G., Ho, I. K., Andrew, M., & Farley, J. M. (1991) · Brain Research Bulletin · doi:10.1016/0361-9230(91)90052-l · Cited by 52
Lin, R., Castells, J., & Rapoport, H. (1998) · The Journal of Organic Chemistry · doi:10.1021/jo980153t · Cited by 51
Meltzer, P. C., Liang, A. Y., & Madras, B. K. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950463t · Cited by 48
(−)-3β-Substituted Ecgonine Methyl Esters as Inhibitors for Cocaine Binding and Dopamine Uptake
Lieske, S. F., Yang, B., Eldefrawi, M. E., MacKerell, A. D., & Wright, J. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970025h · Cited by 48
Dutta, A. K., Coffey, L. L., & Reith, M. E. A. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960638e · Cited by 48
Differing Neurotoxic Potencies of Methamphetamine, Mazindol, and Cocaine in Mesencephalic Cultures
Bennet, B. A., Hyde, C. E., Pecora, J. R., & Clodfelter, J. E. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03307.x · Cited by 47
Neisewander, J. L., O’Dell, L. E., & Redmond, J. C. (1995) · Brain Research · doi:10.1016/0006-8993(94)01317-b · Cited by 44
Davies, H. M. L., Kuhn, L. A., Thornley, C., Matasi, J. J., Sexton, T., & Childers, S. R. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9600508 · Cited by 43
Dutta, A. K., Xu, C., & Reith, M. E. A. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9506581 · Cited by 42
Ritz, M. C., & George, F. R. (1997) · Psychopharmacology · doi:10.1007/s002130050198 · Cited by 42
[3H]WIN 35,065–2: A Ligand for Cocaine Receptors in Striatum
Ritz, M. C., Boja, J. W., Grigoriadis, D. E., Zaczek, R. C., Carroll, F. I., Lewis, A. H., & Kuhar, M. J. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04938.x · Cited by 41
Xu, C., Coffey, L. L., & Reith, M. E. A. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)00485-5 · Cited by 39
Kelkar, S. V., Izenwasser, S., Katz, J. L., Klein, C. L., Zhu, N., & Trudell, M. L. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00049a004 · Cited by 39
Highly potent cocaine analogs cause long-lasting increases in locomotor activity
Fleckenstein, A. E., Kopajtic, T. A., Boja, J. W., Carroll, F. I., & Kuhar, M. J. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00423-2 · Cited by 38
[3H]WIN 35,428 binding to the dopamine uptake carrier. I. Effect of tonicity and buffer composition
Coffey, L. L., & Reith, M. E. A. (1994) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(94)90022-1 · Cited by 37
δ-Opioid receptor antagonists attenuate motor activity induced by amphetamine but not cocaine
Jones, D. N. C., Bowen, W. D., Portoghese, P. S., & Holtzman, S. G. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90429-l · Cited by 36
Angel, I., Taranger, M.-A., Claustre, Y., Scatton, B., & Langer, S. Z. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90135-x · Cited by 33
Current Pharmacotherapies for Cocaine Abuse:
Tutton, C. S., & Crayton, J. W. (1993) · Journal of Addictive Diseases · doi:10.1300/j069v12n02_08 · Cited by 32
Dopaminergic agents for the treatment of cocaine abuse
Smith, M. P., Hoepping, A., Johnson, K. M., Trzcińska, M., & Kozikowski, A. P. (1999) · Drug Discovery Today · doi:10.1016/s1359-6446(99)01332-x · Cited by 32
Piercey, M. F., Lum, J. T., Hoffmann, W. E., Carlsson, A., Ljung, E., & Svensson, K. A. (1992) · Brain Research · doi:10.1016/0006-8993(92)91578-3 · Cited by 32
Novel Benztropine [3a-(Diphenylmethoxy)tropane] Analogs as Probes for the Dopamine Transporter
Newman, A. H., & Agoston, G. E. (1998) · Current Medicinal Chemistry · doi:10.2174/0929867305666220314215936 · Cited by 27
Smith, M. P., George, C. F., & Kozikowski, A. P. (1998) · Tetrahedron Letters · doi:10.1016/s0040-4039(97)10524-x · Cited by 26
Locomotor stimulant effects of cocaine and novel cocaine analogs in DBA/2J and C57BL/6J inbred mice
Tolliver, B. K., & Carney, J. M. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)00277-p · Cited by 23
Anxiolysis by ethanol, diazepam and buspirone in a novel murine behavioral assay
Seale, T. W., Niekrasz, I., & Garrett, K. M. (1996) · Neuroreport · doi:10.1097/00001756-199607290-00023 · Cited by 21
Design and synthesis of a cocaine-diamide hapten for vaccine development
Sakurai, M., Wirsching, P., & Janda, K. D. (1996) · Tetrahedron Letters · doi:10.1016/0040-4039(96)01170-7 · Cited by 19
Xu, L., Kelkar, S. V., Lomenzo, S. A., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960739c · Cited by 15
Galinier, E., Garreau, L., Dognon, A. M., et al. (1993) · European Journal of Medicinal Chemistry · doi:10.1016/0223-5234(93)90047-i · Cited by 7
Metadata
- Authors
- Singh, S.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2000-02-23
- Volume
- 100
- Issue
- 3
- Pages
- 925-1024
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W1969976916
- Cited by
- 267
- References
- 165
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.